Clene CLNN
NASDAQ CLNN
$3.65 -0.07 (-1.88%)
At close: Sep 10, 2026 · 4:00 PM EDT

Clene (CLNN) Non Operating Interest Expenses (2020 - 2026)

Clene (CLNN) posted Non Operating Interest Expenses of $695000.0 for Q2 2026, down 6.84% on a QoQ basis from $746000.0 in Q4 2025, and up 2.36% year-over-year from $679000.0 in Q2 2025.

Analysis

Clene (CLNN) Non Operating Interest Expenses (2020 - 2026) Analysis & Trends

Clene has reported Non Operating Interest Expenses for 7 years, with the latest figure at $695000.0 in Q2 2026.

  • On a quarterly basis, Non Operating Interest Expenses rose 2.36% year-over-year to $695000.0 in Q2 2026; TTM through Jun 2026 was $2.8 million, a 1.98% decrease from a year earlier, with the FY2025 full-year figure at $2.7 million, down 34.01% from the prior year.
  • Non Operating Interest Expenses was $695000.0 for Q2 2026 at Clene, down from $746000.0 in the prior quarter.
  • The five-year high for Non Operating Interest Expenses was $1.3 million in Q2 2024, with the low at $516000.0 in Q4 2024.
  • Average Non Operating Interest Expenses over 5 years is $899705.9, with a median of $857000.0 recorded in 2022.
  • The sharpest annual moves came in 2022 and 2024: Non Operating Interest Expenses jumped 2788.46% in 2022, then tumbled 57.0% in 2024.
  • Over 5 years, Non Operating Interest Expenses stood at $906000.0 in 2022, then surged by 32.45% to $1.2 million in 2023, then slumped by 57.0% to $516000.0 in 2024, then jumped by 44.57% to $746000.0 in 2025, then dropped by 6.84% to $695000.0 in 2026.
  • The last three Non Operating Interest Expenses figures came in at $695000.0 (Q2 2026), $746000.0 (Q4 2025), and $649000.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn 281.00 Mn
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn -
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn -
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn -462.00 Mn
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn -
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn -333.60 Mn
7 Revolution Medicines 42.88 Bn 42.88 Bn - 23.78 Mn
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn 582,000.00
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn 2.90 Mn
10 Clene 45.69 Mn 45.69 Mn 54,000.00 695,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 695,000.00
Dec 31, 2025 746,000.00
Sep 30, 2025 649,000.00
Jun 30, 2025 679,000.00
Mar 31, 2025 608,000.00
Dec 31, 2024 516,000.00
Sep 30, 2024 1.02 Mn
Jun 30, 2024 1.28 Mn
Mar 31, 2024 1.24 Mn
Dec 31, 2023 1.20 Mn
Sep 30, 2023 1.19 Mn
Jun 30, 2023 1.10 Mn
Mar 31, 2023 1.07 Mn
Dec 31, 2022 906,000.00
Sep 30, 2022 857,000.00
Jun 30, 2022 751,000.00
Mar 31, 2022 782,000.00
Jun 30, 2021 26,000.00
Mar 31, 2021 551,000.00
Jun 30, 2020 190,000.00